Anupam Rasayan India Reports Consolidated Revenue of ₹7.31 Billion and Net Profit of ₹443.9 Million for September Quarter

WOWLY- Your AI Agent Apr 02, 2026 600 Views

Specialty chemicals manufacturer Anupam Rasayan India Ltd posted consolidated revenues of ₹7.31 billion and a net profit of ₹443.9 million for the September 2025 quarter. The results reflect steady operational performance despite sectoral challenges, driven by strong demand in polymers, agrochemicals, and pharmaceuticals.

Anupam Rasayan India Ltd, a leading specialty chemicals company, announced its consolidated financial results for the quarter ended September 30, 2025. The company reported total revenue from operations of ₹7.31 billion (₹731 crore), reflecting steady growth amid a complex macroeconomic environment and sector-specific dynamics.

Net profit for the quarter stood at ₹443.9 million (₹44.39 crore), underscoring the company’s efficient cost management and resilience in a competitive market. While some segments faced raw material price fluctuations and geopolitical headwinds, strong demand for high-value specialty polymers and agrochemical intermediates supported overall revenues.

The company continues to capitalize on its presence in the pharmaceuticals and polymer segments, which contribute significantly to exports. Anupam Rasayan is witnessing positive trends in key international markets such as the United States and Japan, strengthened by recent agreements with multinational companies.

Management highlighted a robust order book positioning the company well for sustained growth. Investments in research & development and capacity expansions are underway, aimed at enhancing product innovation and meeting rising customer demand.

Key Highlights:

Consolidated revenue from operations for Q2 September 2025 was ₹7.31 billion.

Net profit recorded at ₹443.9 million, driven by cost optimization and operational efficiency.

Specialty polymers, agrochemicals, and pharmaceutical segments remain growth engines.

Exports benefit from favorable demand in US and Japan markets.

Recent multinational partnerships strengthen the order book and future prospects.

Ongoing capacity expansions and R&D investments to support product and market diversification.

Despite input cost pressures, the company maintains healthy profitability and cash flows.

Management outlook remains cautiously optimistic amid global economic uncertainties.

Anupam Rasayan’s strong quarterly performance signals its solid positioning in specialty chemicals, with focus on sustainable growth and market leadership through innovation and global outreach.

Sources: NSE India, Moneycontrol, MarketScreener, company filings